Literature DB >> 21864830

Acceptance and commitment therapy versus tinnitus retraining therapy in the treatment of tinnitus: a randomised controlled trial.

Vendela Zetterqvist Westin1, Mikael Schulin, Hugo Hesser, Marianne Karlsson, Reza Zare Noe, Ulrike Olofsson, Magnus Stalby, Gisela Wisung, Gerhard Andersson.   

Abstract

The study compared the effects of Acceptance and Commitment Therapy (ACT) with Tinnitus Retraining Therapy (TRT) on tinnitus impact in a randomised controlled trial. Sixty-four normal hearing subjects with tinnitus were randomised to one of the active treatments or a wait-list control (WLC). The ACT treatment consisted of 10 weekly 60 min sessions. The TRT treatment consisted of one 150 min session, one 30 min follow-up and continued daily use of wearable sound generators for a recommended period of at least 8h/day for 18 months. Assessments were made at baseline, 10 weeks, 6 months and 18 months. At 10 weeks, results showed a superior effect of ACT in comparison with the WLC regarding tinnitus impact (Cohen's d=1.04), problems with sleep and anxiety. The results were mediated by tinnitus acceptance. A comparison between the active treatments, including all assessment points, revealed significant differences in favour of ACT regarding tinnitus impact (Cohen's d=0.75) and problems with sleep. At 6 months, reliable improvement on the main outcome measure was found for 54.5% in the ACT condition and 20% in the TRT condition. The results suggest that ACT can reduce tinnitus distress and impact in a group of normal hearing tinnitus patients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21864830     DOI: 10.1016/j.brat.2011.08.001

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  31 in total

1.  Effect of Tinnitus Retraining Therapy vs Standard of Care on Tinnitus-Related Quality of Life: A Randomized Clinical Trial.

Authors:  Roberta W Scherer; Craig Formby
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-07-01       Impact factor: 6.223

2.  Acceptance as a mediator in internet-delivered acceptance and commitment therapy and cognitive behavior therapy for tinnitus.

Authors:  Hugo Hesser; Vendela Zetterqvist Westin; Gerhard Andersson
Journal:  J Behav Med       Date:  2013-07-24

Review 3.  Internet/smartphone-based applications for the treatment of tinnitus: a systematic review.

Authors:  Megha Kondli Nagaraj; Prashanth Prabhu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-12-05       Impact factor: 2.503

4.  Efficacy of Tinnitus Retraining Therapy, A Modish Management of Tinnitus: Our Experience.

Authors:  K Vasu Kumar Reddy; V Krishna Chaitanya; G Ramesh Babu
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-23

5.  Measuring Acceptance of Sleep Difficulties: The Development of the Sleep Problem Acceptance Questionnaire.

Authors:  Kristoffer Bothelius; Susanna Jernelöv; Mats Fredrikson; Lance M McCracken; Viktor Kaldo
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

Review 6.  Cognitive behavioral therapy for tinnitus: evidence and efficacy.

Authors:  Hyung Jin Jun; Moo Kyun Park
Journal:  Korean J Audiol       Date:  2013-12-13

Review 7.  Evolving the future: toward a science of intentional change.

Authors:  David Sloan Wilson; Steven C Hayes; Anthony Biglan; Dennis D Embry
Journal:  Behav Brain Sci       Date:  2014-05-15       Impact factor: 12.579

8.  Rationale for the tinnitus retraining therapy trial.

Authors:  Craig Formby; Roberta Scherer
Journal:  Noise Health       Date:  2013 Mar-Apr       Impact factor: 0.867

9.  The Tinnitus Retraining Therapy Counseling Protocol as Implemented in the Tinnitus Retraining Therapy Trial.

Authors:  Susan L Gold; Craig Formby; Roberta W Scherer
Journal:  Am J Audiol       Date:  2020-12-01       Impact factor: 1.493

10.  Mindfulness-and body-psychotherapy-based group treatment of chronic tinnitus: a randomized controlled pilot study.

Authors:  Peter M Kreuzer; Monika Goetz; Maria Holl; Martin Schecklmann; Michael Landgrebe; Susanne Staudinger; Berthold Langguth
Journal:  BMC Complement Altern Med       Date:  2012-11-28       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.